Scarica l'app Stockscreener
5.3128
3.97%
-0.2272
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation ReviewWhat's Changed - simplywall.st
SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout - Stocktwits
Wall Street Recap: Can SELLAS Life Sciences Group Inc beat the S P 500July 2025 Sentiment & Safe Entry Trade Signal Reports - baoquankhu1.vn
SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside - Stocktwits
What's Going With SELLAS Life Sciences Stock On Wednesday? - Bitget
Bull Run: Will SELLAS Life Sciences Group Inc benefit from green energy policiesWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
SLS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SELLAS Life Sciences Group (NASDAQ:SLS) Hits New 12-Month HighTime to Buy? - MarketBeat
SLS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SLS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
SLS Technical Analysis & Stock Price Forecast - Intellectia AI
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN
Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% - Asianet Newsable
SELLAS Life Sciences Group Target of Unusually Large Options Trading (NASDAQ:SLS) - MarketBeat
Stock Surge: Solstice Minerals Breakthrough at Nanadie Adventure - timothysykes.com
Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play - Bez Kabli
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 9.8%Here's Why - MarketBeat
Solstice Minerals Shares Surge 56% on Successful Drilling Results - StocksToTrade
Anson group discloses 4.9% SELLAS Life Sciences (SLS) stake via 13G/A - Stock Titan
Profit Review: What is the target price for Green Dot Corporation stockJuly 2025 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Is SELLAS Life Sciences Group Inc.’s ROIC above industry average2025 Fundamental Recap & Long-Term Investment Growth Plans - mfd.ru
SLS PE Ratio & Valuation, Is SLS Overvalued - Intellectia AI
Why SELLAS Life Sciences Group Inc. stock attracts global investorsQuarterly Portfolio Review & Verified Entry Point Detection - mfd.ru
Sentiment Recap: Can SELLAS Life Sciences Group Inc beat the S P 500Dip Buying & Short-Term High Return Ideas - baoquankhu1.vn
What’s the beta of SELLAS Life Sciences Group Inc. stockGap Down & Weekly High Conviction Trade Ideas - mfd.ru
Surprises Report: Is Freeport McMoRan Incs growth already priced inQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap DownShould You Sell? - MarketBeat
Market Review: How correlated is SPKLU to the S P5002025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Forecast Cut: Does SELLAS Life Sciences Group Inc align with a passive investing strategyMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Pharma News: Can SELLAS Life Sciences Group Inc stock double in the next year2025 Key Highlights & Community Consensus Picks - baoquankhu1.vn
Aug Ideas: Should I hold or sell SELLAS Life Sciences Group Inc nowBull Run & AI Optimized Trade Strategies - baoquankhu1.vn
Everhart Financial Group Inc. Takes Position in SELLAS Life Sciences Group, Inc. $SLS - MarketBeat
Can SELLAS Life Sciences Group Inc beat the S P 5002025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Can SELLAS Life Sciences Group Inc. stock double in the next yearRate Cut & Low Volatility Stock Recommendations - mfd.ru
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 7.4%Should You Sell? - MarketBeat
SLS Stock Nears 52-Week High Amid Market Turbulence: What It Means for Investors - StocksToTrade
Heightened Volatility Marks Sellas Life Sciences as Key Clinical Milestones Approach - AD HOC NEWS
SLS Stock Price, Forecast & Analysis | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - Chartmill
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Rises as Traders Weigh REGAL Debate and Microcap Volatility - StocksToTrade
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS) - Seeking Alpha
Will SELLAS Life Sciences Group Inc. stock see PE expansion2025 Pullback Review & Proven Capital Preservation Methods - bollywoodhelpline.com
Sellas Life Sciences Shares Surge with Strategic Clinical Study Moves - StocksToTrade
SELLAS Life Sciences’ European Partnership Spurs Market Optimism - timothysykes.com
Key Developments in SLS’s Market Strategy - StocksToTrade
SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st
Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade
Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe - Sahm
SELLAS partners with IMPACT-AML for European SLS009 trials By Investing.com - Investing.com Nigeria
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement - Yahoo Finance
How SELLAS’s IMPACT-AML Trial Expansion At SELLAS Life Sciences Group (SLS) Has Changed Its Investment Story - simplywall.st
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):